Rheumatoid Arthritis Drugs Market is Expected to Expand at a CAGR of 2.96% from 2018 to 2026

Š2019 Transparency Market Research, All Rights Reserved

Rheumatoid Arthritis Drugs Market Drug Type - Disease-modifying Anti-rheumatic Drugs (DMARDs), Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Biologic Response Modifiers (Biologics); Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Forecast From 2018 - 2026

Š2019 Transparency Market Research, All Rights Reserved

Š2019 Transparency Market Research, All Rights Reserved

Table of Content Sr. No.

Content

Chapter 1

Preface

Chapter 2

Assumptions and Research Methodology

Chapter 3

Executive Summary

Chapter 4

Market Overview

Chapter 5

Market Outlook

Chapter 6

Global Rheumatoid Arthritis Drugs Market Analysis, by Drug Type

Chapter 7

Global Rheumatoid Arthritis Drugs Market Analysis, by Distribution Channel

Chapter 8

Global Rheumatoid Arthritis Drugs Market Analysis, by Region

Chapter 9

North America Rheumatoid Arthritis Drugs Market Analysis

Chapter 10

Europe Rheumatoid Arthritis Drugs Market Analysis

Chapter 11

Asia Pacific Rheumatoid Arthritis Drugs Market Analysis

Chapter 12

Latin America Rheumatoid Arthritis Drugs Market Analysis

Chapter 13

Middle East & Africa Rheumatoid Arthritis Drugs Market Analysis

Chapter 14

Competitive Landscape

©2019 Transparency Market Research, All Rights Reserved

Snapshot: •

Rheumatoid arthritis is an autoimmune disorder that causes pain and inflammation in the joints. In this disease, the immune system mistakenly affects the joints, causing inflammation and pain in the joints throughout the body.

•

Rise in geriatric population, high prevalence of rheumatoid arthritis, and increase in patient preference for biological origin drugs are major drivers of the global rheumatoid arthritis drugs market.

•

global rheumatoid arthritis drugs market can be segmented based on drug type, distribution channel, and geography.

©2019 Transparency Market Research, All Rights Reserved

Š2019 Transparency Market Research, All Rights Reserved

©2019 Transparency Market Research, All Rights Reserved

Reports Highlights • Global rheumatoid arthritis drugs market is expected to expand at a CAGR of 2.96% from 2018 to 2026. In 2016, the global market was valued at US$ 19597.43 Mn. • Key Players – Pfizer, Inc., Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bristol-Myers Squibb Company, and Eli Lilly and Company.

©2019 Transparency Market Research, All Rights Reserved

Request Sample

Š2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website:

www.transparencymarketresearch.com For sales queries or new topics email us on:

sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030

T

H

A Y

N O

K U